|
NAALADL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.15150111668072E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.11590025687303E-10 |
| Normal-vs-Stage2 |
4.14769999457221E-08 |
| Normal-vs-Stage3 |
7.95329999636607E-08 |
| Normal-vs-Stage4 |
1.40790046287975E-10 |
| Stage1-vs-Stage2 |
3.802000E-01 |
| Stage1-vs-Stage3 |
4.045400E-01 |
| Stage1-vs-Stage4 |
5.100600E-03 |
| Stage2-vs-Stage3 |
9.399000E-01 |
| Stage2-vs-Stage4 |
1.677230E-01 |
| Stage3-vs-Stage4 |
1.837380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74182890333441E-12 |
| Normal-vs-AfricanAmerican |
3.17499999957782E-07 |
| Normal-vs-Asian |
3.61159990802662E-10 |
| Caucasian-vs-AfricanAmerican |
4.019600E-01 |
| Caucasian-vs-Asian |
3.082700E-03 |
| AfricanAmerican-vs-Asian |
9.426500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.78117545554824E-12 |
| Normal-vs-Female |
6.69890000137841E-08 |
| Male-vs-Female |
9.247000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.81089999849038E-08 |
| Normal-vs-Extreme_Weight |
1.68642877440561E-12 |
| Normal-vs-Obese |
8.46880343630119E-11 |
| Normal-vs-Extreme_Obese |
6.562200E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.224000E-01 |
| Normal_Weight-vs-Obese |
6.858800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.937800E-01 |
| Extreme_Weight-vs-Obese |
4.543200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.870000E-01 |
| Obese-vs-Extreme_Obese |
4.113000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.04979999998789E-06 |
| Normal-vs-Age(41-60Yrs) |
4.7974000327855E-09 |
| Normal-vs-Age(61-80Yrs) |
2.59060550789059E-11 |
| Normal-vs-Age(81-100Yrs) |
8.79318839963616E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.912400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.395800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.184400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.476200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.782180E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.916400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.74005254649501E-12 |
| Normal-VS-Type2 PRCC |
1.02419994707503E-09 |
| Normal-VS-KIRP CIMP |
1.80463999999159E-05 |
| Normal-VS-Unclassified PRCC |
2.08379999999675E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.212390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.530000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.311400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.182800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.188000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.825200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.19566636778291E-13 |
| Normal-vs-N1 |
1.49109946612214E-10 |
| Normal-vs-N2 |
2.621400E-04 |
| N0-vs-N1 |
8.222000E-01 |
| N0-vs-N2 |
5.649000E-01 |
| N1-vs-N2 |
5.566800E-01 |
|
|
